BCS Financial (BCS), a market leading insurer and reinsurer today announced its partnership with the National Hemophilia Foundation (NHF), bringing to market a solution set for health plans and their members to improve the quality and cost of care.
Founded in 1948, NHF strives to provide better treatments and cures for inheritable bleeding disorders and prevent complications of these disorders through education, advocacy and research.
“The partnership between the NHF and BCS and its member plans allow us to establish baseline data on payment claims for people with hemophilia and develop strategies for Blue payers to facilitate the delivery of high-quality care through the network of federally-funded hemophilia treatment centers,” said Leonard A. Valentino, MD, president & CEO of NHF. “BCS supports our goal to ensure optimal patient outcomes at the lowest possible cost.”
There are approximately 20,000 individuals with hemophilia, and hemophilia consistently ranks within the top 10 highest catastrophic case spends. Costs range several hundred thousand dollars per year, with more than $1 million in annual costs is not unheard of for patients with the most severe forms of the disease (Source: Optum).
“The partnership with NHF, a trusted advocacy organization aligned with our focus on assisting with quality and cost of care, is a first-of-its-kind in the industry,” said Peter Costello, president and chief executive officer of BCS, “NHF’s unique ability to advise on optimal care management truly benefits our customers not only with cost but the level of service we strive to provide.”
The three major factors affecting hemophilia cost containment include:
- Site of care - hemophilia treatment center Gold Standard
- Assay management
- Prescription management
The partnership addresses all three factors providing customers with increased access to BCS and its broad portfolio of complementary products including excess of loss, stop loss, international health, limited benefit, and group supplemental insurance.
Source: BCS Financial press release, Nov. 17, 2020
